293 related articles for article (PubMed ID: 26117455)
1. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
[TBL] [Abstract][Full Text] [Related]
2. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia.
Altintas E; Sezgin O
Med Hypotheses; 2004; 63(5):834-7. PubMed ID: 15488656
[TBL] [Abstract][Full Text] [Related]
3. S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population.
Zawada AM; Rogacev KS; Hummel B; Berg JT; Friedrich A; Roth HJ; Obeid R; Geisel J; Fliser D; Heine GH
Atherosclerosis; 2014 May; 234(1):17-22. PubMed ID: 24589563
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Xiao Y; Huang W; Zhang J; Peng C; Xia M; Ling W
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):60-70. PubMed ID: 25359864
[TBL] [Abstract][Full Text] [Related]
5. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology.
James SJ; Melnyk S; Pogribna M; Pogribny IP; Caudill MA
J Nutr; 2002 Aug; 132(8 Suppl):2361S-2366S. PubMed ID: 12163693
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of S-Adenosylhomocysteine Hydrolase Induces Endothelial Dysfunction via Epigenetic Regulation of p66shc-Mediated Oxidative Stress Pathway.
Xiao Y; Xia J; Cheng J; Huang H; Zhou Y; Yang X; Su X; Ke Y; Ling W
Circulation; 2019 May; 139(19):2260-2277. PubMed ID: 30773021
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
8. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
Fu W; Dudman NP; Perry MA; Young K; Wang XL
Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
[TBL] [Abstract][Full Text] [Related]
9. S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase.
Christopher SA; Melnyk S; James SJ; Kruger WD
Mol Genet Metab; 2002 Apr; 75(4):335-43. PubMed ID: 12051965
[TBL] [Abstract][Full Text] [Related]
10. No Effect of Diet-Induced Mild Hyperhomocysteinemia on Vascular Methylating Capacity, Atherosclerosis Progression, and Specific Histone Methylation.
Whalen CA; Mattie FJ; Florindo C; van Zelst B; Huang NK; Tavares de Almeida I; Heil SG; Neuberger T; Ross AC; Castro R
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32717800
[TBL] [Abstract][Full Text] [Related]
11. Ratio of S-adenosylmethionine to S-adenosylhomocysteine as a sensitive indicator of atherosclerosis.
Zhang H; Liu Z; Ma S; Zhang H; Kong F; He Y; Yang X; Wang Y; Xu H; Yang A; Tian J; Zhang M; Cao J; Jiang Y; Guo X
Mol Med Rep; 2016 Jul; 14(1):289-300. PubMed ID: 27175774
[TBL] [Abstract][Full Text] [Related]
12. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice.
Jiang Y; Zhang H; Sun T; Wang J; Sun W; Gong H; Yang B; Shi Y; Wei J
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):866-75. PubMed ID: 23017835
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
[TBL] [Abstract][Full Text] [Related]
14. Methionine Metabolites in Patients With Sepsis.
Wexler O; Gough MS; Morgan MAM; Mack CM; Apostolakos MJ; Doolin KP; Mooney RA; Arning E; Bottiglieri T; Pietropaoli AP
J Intensive Care Med; 2018 Jan; 33(1):37-47. PubMed ID: 27591199
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in hyperhomocysteinemic states. A special focus on uremia.
Ingrosso D; Perna AF
Biochim Biophys Acta; 2009 Sep; 1790(9):892-9. PubMed ID: 19245874
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study.
Van Hecke MV; Dekker JM; Nijpels G; Teerlink T; Jakobs C; Stolk RP; Heine RJ; Bouter LM; Polak BC; Stehouwer CD
Clin Sci (Lond); 2008 Apr; 114(7):479-87. PubMed ID: 17956228
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs.
Yideng J; Jianzhong Z; Ying H; Juan S; Jinge Z; Shenglan W; Xiaoqun H; Shuren W
DNA Cell Biol; 2007 Aug; 26(8):603-11. PubMed ID: 17688412
[TBL] [Abstract][Full Text] [Related]
18. Lack of global epigenetic methylation defects in CBS deficient mice.
Lee HO; Wang L; Kuo YM; Gupta S; Slifker MJ; Li YS; Andrews AJ; Kruger WD
J Inherit Metab Dis; 2017 Jan; 40(1):113-120. PubMed ID: 27444757
[TBL] [Abstract][Full Text] [Related]
19. Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet.
Poirier LA; Wise CK; Delongchamp RR; Sinha R
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):649-55. PubMed ID: 11401915
[TBL] [Abstract][Full Text] [Related]
20. Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells.
Brown KS; Huang Y; Lu ZY; Jian W; Blair IA; Whitehead AS
Atherosclerosis; 2006 Nov; 189(1):133-41. PubMed ID: 16469322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
